Method for discriminating synchronous multiple lung cancers of the same histological type: miRNA expression analysis

Area of Science:

• Oncology
• Genomics
• Diagnostic Medicine

Background:

• Increasingly sophisticated imaging detects more synchronous multiple lung cancers (SMLCs).
• Distinguishing synchronous multiple primary lung cancers (SMPLCs) from metastases is crucial for accurate patient management.
• Current diagnostic methods, including histology and molecular analysis, face limitations in differentiating SMPLCs of the same histological type.

Purpose of the Study:

• To evaluate the utility of microRNA (miRNA) expression profiling in distinguishing SMPLCs of the same histological type from intrapulmonary metastases.
• To assess the diagnostic accuracy of miRNA analysis compared to integrated clinical, histological, and molecular assessments.

Main Methods:

• Analysis of 24 patients with same-histological-type SMLCs.
• Utilized differential microRNA (miRNA) expression profiles (ΔΔCt) between matched tumors.
• Compared miRNA analysis results with established clinical guidelines, histological subtyping, and molecular diagnostics.
• Included 12 patients with lymph node metastases for comparative analysis.

Main Results:

• The sum value of ΔΔCt for 5 miRNAs between primary tumors and lymph node metastases was consistently <9.
• miRNA analysis classified patients diagnosed with SMPLCs by integrated analysis as SMPLCs.
• Six patients presented conflicting diagnoses between integrated and miRNA analyses, while 14 received concordant classifications.

Conclusions:

• MicroRNA expression profiling serves as a valuable tool for discriminating between synchronous multiple primary lung cancers (SMPLCs) and intrapulmonary metastases.
• miRNA analysis can aid in resolving diagnostic ambiguities for SMPLCs of the same histological type.